Clinical Trial Detail

NCT ID NCT02964559
Title Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

skin squamous cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.